Johnson & Johnson research director discusses team building By LINDA A. JOHNSON - Associated Press Shares
Johnson & Johnson puts up strong profit and revenue in 4Q By LINDA A. JOHNSON - Associated Press Shares
Johnson & Johnson tops 1Q views on sales spike, but net dips By LINDA A. JOHNSON - Associated Press Shares
Johnson & Johnson tops Street 3Q forecasts, hikes forecast By LINDA A. JOHNSON - Associated Press Shares
Drugmaker paying $33M over recalled nonprescription meds By LINDA A. JOHNSON - Associated Press Shares
FDA approves 2nd near-copy of Remicade for immune disorders By LINDA A. JOHNSON - Associated Press Shares